Chemoinformaics analysis of Ramonanin B, (rel)-
| Molecular Weight | 680.75 | nRot | 8 |
| Heavy Atom Molecular Weight | 640.43 | nRig | 40 |
| Exact Molecular Weight | 680.262 | nRing | 7 |
| Solubility: LogS | -4.118 | nHRing | 2 |
| Solubility: LogP | 4.706 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 90 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 50 | No. of Aromatic Carbocycles | 4 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 40 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 24 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 24 |
| nHA | 10 | APOL | 101.492 |
| nHD | 4 | BPOL | 50.5443 |
| QED | 0.136 |
| Synth | 5.181 |
| Natural Product Likeliness | 1.053 |
| NR-PPAR-gamma | 0.976 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.922 |
| Pgp-sub | 0.041 |
| HIA | 0.073 |
| CACO-2 | -5.842 |
| MDCK | 0.00000549 |
| BBB | 0.002 |
| PPB | 0.966878 |
| VDSS | 0.441 |
| FU | 0.0341686 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.841 |
| CYP2c19-inh | 0.543 |
| CYP2c19-sub | 0.491 |
| CYP2c9-inh | 0.645 |
| CYP2c9-sub | 0.915 |
| CYP2d6-inh | 0.025 |
| CYP2d6-sub | 0.937 |
| CYP3a4-inh | 0.528 |
| CYP3a4-sub | 0.905 |
| CL | 7.755 |
| T12 | 0.079 |
| hERG | 0.037 |
| Ames | 0.065 |
| ROA | 0.883 |
| SkinSen | 0.645 |
| Carcinogencity | 0.02 |
| EI | 0.866 |
| Respiratory | 0.853 |
| NR-Aromatase | 0.852 |
| Antiviral | Yes |
| Prediction | 0.944153 |